Drug Patent Expirations in December 2009

Drug Patent Expirations for December 2009

Tradename Applicant Generic Name Patent Number Patent Expiration
MIGRANAL Valeant dihydroergotamine mesylate 5,169,849 Dec 8, 2009
PHOTOFRIN Axcan Scandipharm porfimer sodium 5,145,863 Dec 15, 2009
XENICAL Hoffmann La Roche orlistat 4,598,089*PED Dec 18, 2009
CEDAX Sciele Pharma Inc ceftibuten dihydrate 4,812,561 Dec 20, 2009
OXILAN-300 Guerbet ioxilan 4,954,348 Dec 21, 2009
OXILAN-350 Guerbet ioxilan 4,954,348 Dec 21, 2009
DEFINITY Lantheus Medcl perflutren 6,146,657 Dec 22, 2009
ZANTAC 150 Glaxosmithkline ranitidine hydrochloride 5,102,665*PED Dec 23, 2009
VALTREX Glaxosmithkline valacyclovir hydrochloride 4,957,924*PED Dec 23, 2009
ZIAGEN Glaxosmithkline abacavir sulfate 5,089,500*PED Dec 26, 2009
TRIZIVIR Glaxosmithkline abacavir sulfate; lamivudine; zidovudine 5,089,500*PED Dec 26, 2009
EPZICOM Smithkline Beecham abacavir sulfate; lamivudine 5,089,500*PED Dec 26, 2009
CORVERT Pharmacia And Upjohn ibutilide fumarate 5,155,268 Dec 28, 2009

*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.


Leave a Reply